Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Iron Deficiency
Interventions
DRUG

Quadruple sequential Helicobacter pylori eradication + iron sulfate

A 10-day course of Hp infection sequential eradication therapy plus 6-weeks of iron supplementation

DRUG

Quadruple sequential Helicobacter pylori eradication therapy

A 10-day course of Hp infection sequential eradication therapy only plus 6-weeks of matching placebo of iron supplementation

DRUG

Ferrous sulfate

6-weeks of iron supplementation only plus 10-days matching placebo of Hp infection eradication therapy

DRUG

Placebo

Placebo only (10-days of matching placebo of Hp eradication therapy and 6-weeks of matching iron supplementation).

Trial Locations (1)

79905

Texas Tech University School of Medicine, El Paso

All Listed Sponsors
collaborator

Texas Tech University

OTHER

collaborator

University of Texas

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

University of North Texas Health Science Center

OTHER

lead

The University of Texas Health Science Center, Houston

OTHER

NCT00364104 - Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children | Biotech Hunter | Biotech Hunter